Skip to main content

Bogart Wealth, LLC

SEC CIK
0001715740
Latest filing
Jul 24, 2026

HALO holding history

Halozyme Therapeutics, Inc. in every 13F filed by Bogart Wealth, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

HALO overviewAll 13F holders of HALOFull Q2 2026 holdings

Shares (Q2 2026)
52
Value
$4.07K
% of portfolio
<0.1%
Quarters held
2
Since Q3 2022
Holdings of HALO by Bogart Wealth, LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 202652$4.07K<0.1%+52NewHolders
Q4 20220$00.0%−50−100.0%Sold outHolders
Q3 202250$2.00K<0.1%+50NewHolders